Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NARCT vs TNT in T3 Rectal Cancer
NCT06097416Phase 3Not yet recruiting
- Sponsor
- St James's Hospital
- Start
- Oct 2024
- Primary completion
- Oct 2025
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 3 trial of oxaliplatin in rectal cancer, sponsored by St James's Hospital. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
oxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT06097416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06097416.